We only have this paper's title and publication details.
Read it at the sourcePhase 1 trial demonstrates ex vivo axi-cel proliferation with utomilumab in relapsed or refractory large B-cell lymphoma, suggesting potential combinatorial benefits.
Ex vivo Axi-cel Proliferation After Stimulation With Utomilumab
No takes yet. Share an insight, caveat, or question.
Jain et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: